Paris, Île-de-France, France
Voir plus de détails sur le profil en anglais. See English profile. RAPS member
Master 2 ERIEPS - Pharmacy US regulatory affairs and drug development
I lead the global regulatory strategy for products in clinical development (Rare blood disorders/hematology) with a global regulatory team of 14 experts and 4 direct reports
Rare blood disorders, hematology, early and late stage development programs Gene therapy, gene editing Member of BIO regenerative medicine working group
Rare blood disorders, hematology - early and late stage development programs Gene therapy